Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Livongo Health, Inc.    LVGO

LIVONGO HEALTH, INC.

(LVGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/26/2020 06/29/2020 06/30/2020 07/01/2020 07/02/2020 Date
74.99(c) 71.56(c) 75.19(c) 74.41(c) 72.81(c) Last
8 574 802 2 582 615 2 600 843 2 418 055 2 686 979 Volume
+4.81% -4.57% +5.07% -1.04% -2.15% Change
More quotes
Financials (USD)
Sales 2020 301 M - -
Net income 2020 -49,1 M - -
Net cash position 2020 357 M - -
P/E ratio 2020 -169x
Yield 2020 -
Sales 2021 474 M - -
Net income 2021 -34,0 M - -
Net cash position 2021 314 M - -
P/E ratio 2021 -271x
Yield 2021 -
Capitalization 7 122 M 7 122 M -
EV / Sales 2020 22,5x
EV / Sales 2021 14,4x
Nbr of Employees 671
Free-Float 57,3%
More Financials
Company
Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company’s Livongo platform offers a range of solutions, such as Livongo for Diabetes,... 
More about the company
Surperformance© ratings of Livongo Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on LIVONGO HEALTH, INC.
06/29TELEMEDICINE, REMOTE WORKFORCES & LE : CEO’s of LVGO, NEXCF, AVYA, FVRR D..
AQ
06/18Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Uni..
GL
06/04LIVONGO HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a..
AQ
06/02Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior Notes ..
GL
06/01Livongo Announces Proposed Offering of $400.0 Million of Convertible Senior N..
GL
05/26Livongo to Present at Upcoming Investor Conferences
GL
05/22LIVONGO HEALTH, INC. : Submission of Matters to a Vote of Security Holders (form..
AQ
05/12Livongo to Present at Upcoming Investor Conferences
GL
05/07LIVONGO HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/07LIVONGO HEALTH : 1Q Earnings Snapshot
AQ
05/06LIVONGO HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
05/06Livongo Reports First Quarter 2020 Financial Results
GL
04/09Livongo Partners with Prognos Health to Drive More Personalized Health Nudges..
GL
04/07LIVONGO HEALTH : Results of Operations and Financial Condition (form 8-K/A)
AQ
04/07LIVONGO HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
More news
News in other languages on LIVONGO HEALTH, INC.
06/29TELEMEDICINE, REMOTE WORKFORCES & LE : CEO’s of LVGO, NEXCF, AVYA, FVRR D..
06/18Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Uni..
06/04LIVONGO HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a..
06/02Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior Notes ..
06/01Livongo Announces Proposed Offering of $400.0 Million of Convertible Senior N..
More news
Chart LIVONGO HEALTH, INC.
Duration : Period :
Livongo Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIVONGO HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Average target price 66,69 $
Last Close Price 72,81 $
Spread / Highest target 20,9%
Spread / Average Target -8,40%
Spread / Lowest Target -27,2%
EPS Revisions
Managers
NameTitle
Zane M. Burke Chief Executive Officer & Director
Jennifer Schneider President
Glen E. Tullman Executive Chairman
Karl Greiter Senior Vice President-Operations
Lee A. Shapiro Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
LIVONGO HEALTH, INC.190.54%7 122
MEDTRONIC PLC-17.88%124 955
BAXTER INTERNATIONAL INC.4.29%44 376
DEXCOM, INC.86.23%37 617
HOYA CORPORATION0.57%35 259
TERUMO CORPORATION5.74%28 523